XIANYANG, China, November 10, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that it will issue its financial results for the third quarter and nine months ended September 30, 2011 on Monday, November 14th after the close of the market.
Biostar's Chairman and CEO, Ronghua Wang and CFO, Zack Pan will host a conference call on Tuesday, November 15th at 10:30 am ET to discuss these results as well as recent corporate developments.
Live conference call details
Interested parties may participate in the call by dialing (480) 629-9857. Please call in 10 minutes before the conference is scheduled to begin and ask for the Biostar call or use pass code 4487920. After opening remarks, there will be a question and answer period. Questions may be asked during the live call, or alternatively, you may e-mail questions in advance to lcati@equityny.com.
Webcast
The conference call will also be broadcast live over the Internet. To listen to the webcast, please go to http://viavid.net/dce.aspx?sid=00009006 or visit Biostar's website http://www.biostarpharmaceuticals.com and then to the Investors page where the conference call is posted. Please go to the website at least 15 minutes early to register, and download and install any necessary audio software. If you are unable to listen live, the conference call will be archived and can be accessed for approximately 90 days. We suggest listeners use Microsoft Internet Explorer as their web browser.
Replay
A reply will be available until 11:59 pm E.T. November 22, 2011. To listen, please call (858) 384-5517 and use pass code 4487920.
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com.
For more information contact:
Biostar Pharmaceuticals, Inc. | The Equity Group Inc. | |
Zack Pan, CFO | Lena Cati | |
Tel: 405-996-8829 | Tel: 212 836-9611 | |
Email: zpan@aoxing-group.com | Email: lcati@equityny.com | |
